探讨鼠李糖乳酸杆菌GKLC1 (Lacticaseibacillus rhamnosus GKLC1)对胃部保护的作用
To Explore the Protective Effects of Lacticaseibacillus rhamnosus GKLC1 on the Stomach
DOI: 10.12677/hjbm.2024.142020, PDF,   
作者: 邱婕宁, 蔡侑珊, 林 珊, 林诗伟, 陈炎炼：葡萄王生技股份有限公司，台湾 桃园；陈嘉琪：动物科技研究所，农业科技研究院，台湾 苗栗；林静敏：上海葡萄王企业有限公司，上海；陈劲初*：台湾大学食品科技研究所，台湾 台北
关键词: 胃溃疡；幽门螺旋杆菌；非类固醇消炎药；益生菌；胃保护；Gastric Ulcer (GU)； Helicobacter pylori； Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)； Probiotics； Gastric Protection
摘要: 过去研究团队于酒精引起之肝损伤动物试验中，观察到益生菌(probiotics)鼠李糖乳酸杆菌GKLC1 (Lacticaseibacillus rhamnosus GKLC1)不仅具护肝效果，同时在该模式下观察到受酒精影响损伤的胃部组织获保护的效果。因此进一步地，本研究探讨益生菌GKLC1对胃部的保健功效。针对幽门螺旋杆菌(Helicobacter pylori)引起的胃溃疡(gastric ulcer)，以体外试验琼脂纸锭扩散法(agar disk diffusion test)测试益生菌GKLC1对于三种不同株H. pylori的抑制效果。针对非类固醇消炎药(non-steroidal anti-inflammatory drugs, NSAIDs)引起的胃溃疡，则以ICR小鼠连续摄入10天阿斯匹林(500 mg/kg/day Aspirin)诱发胃损伤，评估益生菌GKLC1 (高剂量：20.4 mg/kg/day；低剂量：5.12 mg/kg/day)预先补充对胃保护的效果。结果益生菌GKLC1对于标准病原株H. pylori 26695或临床分离的抗药病原株H. pylori v633、H. pylori v1354皆无抑制表现；然而经Aspirin诱导的胃溃疡，益生菌GKLC1则可显著减少胃溃疡的面积、胃黏膜溃疡深度、以及增加胃溃疡治愈力。综合以上结果，L. rhamnosus GKLC1对于胃部机能具保护功效，特别是饮食、药物引起的伤胃保护，对于微生物引起的胃病则较无效果。
Abstract: In the past, the research team observed in animal experiments on alcohol-induced liver damage that the probiotic Lactobacillus rhamnosus GKLC1 (Lacticaseibacillus rhamnosus GKLC1) not only had a liver-protective effect, but also observed less gastric damage caused by alcohol in this model. Therefore, this study further explores the protective effect of probiotic GKLC1 on the stomach. For gastric ulcers caused by Helicobacter pylori, the in vitro agar disk diffusion test was used to test the inhibitory effect of probiotic GKLC1 on three different strains of H. pylori. For gastric ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs), ICR mice were used to continuously ingest aspirin (500 mg/kg/day) for 10 days to induce gastric damage and evaluate the gastro protective effect of pre-supplementation of probiotics GKLC1 (high dose: 20.4 mg/kg/day; low dose: 5.12 mg/kg/day). Results showed that probiotics GKLC1 had no inhibitory effect on the standard pathogen strain H. pylori 26695 or the clinically isolated drug-resistant pathogen strains H. pylori v633 and H. pylori v1354. However, probiotic GKLC1 could significantly reduce gastric ulcer induced by Aspirin including reducing area of ulcers, the depth of gastric mucosal ulcers, and improving the healing ability of gastric ulcers. Based on the above results, L. rhamnosus GKLC1 has a protective effect on gastric function, especially on gastric injuries caused by diet and drugs, but is less effective on gastric diseases caused by microorganisms.
文章引用：邱婕宁, 蔡侑珊, 林珊, 陈嘉琪, 林诗伟, 林静敏, 陈炎炼, 陈劲初. 探讨鼠李糖乳酸杆菌GKLC1 (Lacticaseibacillus rhamnosus GKLC1)对胃部保护的作用[J]. 生物医学, 2024, 14(2): 179-188. https://doi.org/10.12677/hjbm.2024.142020

参考文献

[1] Khan, A.H., Dar, M.A. and Mir, M.A. (2023) Gastric Ulcer: An Overview. International Journal of Current Research in Physiology and Pharmacology, 7, 1-7.
[2] Martinsen, T.C., Fossmark, R. and Waldum, H.L. (2019) The Phylogeny and Biological Function of Gastric Juice— Microbiological Consequences of Removing Gastric Acid. International Journal of Molecular Sciences, 20, Article 6031. [Google Scholar] [CrossRef] [PubMed]
[3] Sadiq, K., Rizwan, B., Noreen, S., Fatima, A., Sheraz, M., Shafqat, M. and Rashid, H.M. (2020) Determinants of Peptic Ulcer Disease: A Systematic Review. EAS Journal of Nutrition and Food Sciences, 2, 257-264. [Google Scholar] [CrossRef] 
[4] Keikha, M. (2020) Is There a Relationship between Helicobacter pylori vacA i1 or i2 Alleles and Development into Peptic Ulcer and Gastric Cancer? A Meta-Analysis Study on an Iranian Population. New Microbes and New Infections, 36, Article ID: 100726. [Google Scholar] [CrossRef] [PubMed]
[5] Youssefi, M., Tafaghodi, M., Farsiani, H., Ghazvini, K. and Keikha, M. (2021) Helicobacter Pylori Infection and Autoimmune Diseases; Is There an Association with Systemic Lupus Erythematosus, Rheumatoid Arthritis, Autoimmune Atrophy Gastritis and Autoimmune Pancreatitis? A Systematic Review and Meta-Analysis Study. Journal of Microbiology, Immunology and Infection, 54, 359-369. [Google Scholar] [CrossRef] [PubMed]
[6] Gravina, A.G., Zagari, R.M., De Musis, C., Romano, L., Loguercio, C. and Romano, M. (2018) Helicobacter pylori and Extragastric Diseases: A Review. World Journal of Gastroenterology, 24, 3204-3221. [Google Scholar] [CrossRef] [PubMed]
[7] Atkinson, T.J. and Fudin, J. (2020) Nonsteroidal Antiinflammatory Drugs for Acute and Chronic Pain. Physical Medicine and Rehabilitation Clinics, 31, 219-231. [Google Scholar] [CrossRef] [PubMed]
[8] Zakiyah, W., Wibowo, S.P.S., Elyyana, N., Darmawan, S.A.N., Lestari, S.A., Sa’diyyah, N., Mulki, M.A. and Malau,J. (2022) Literature Review: Study of Molecular Mechanism Level of NSAID Class of Drugs as COX-2 Inhibitors. Jurnal EduHealth, 13, 572-580.
[9] Ruan, K.H. and Lu, R. (2023) Latest Advancements in the Study of the Relationship between NSAIDs and Three Prostaglandin E2 Synthases. Future Medicinal Chemistry, 15, 1549-1552. [Google Scholar] [CrossRef] [PubMed]
[10] Takeuchi, K. and Amagase, K. (2018) Roles of Cyclooxygenase, Prostaglandin E2 and EP Receptors in Mucosal Protection and Ulcer Healing in the Gastrointestinal Tract. Current Pharmaceutical Design, 24, 2002-2011. [Google Scholar] [CrossRef] [PubMed]
[11] Tsai, Y.S., Lin, S.W., Wu, W.S., Chen, Y.L. and Chen, C.C. (2021) A Screening of Probiotics for Renal Protection in the Cisplatin-Induced Acute Kidney Injury Animal Model. Hans Journal of Food and Nutrition Science, 10, 330-339. [Google Scholar] [CrossRef] 
[12] Tsai, Y.S., Chen, Y.P., Lin, S.W., Chen, Y.L., Chen, C.C. and Huang, G.J. (2022) Lactobacillus rhamnosus GKLC1 Ameliorates Cisplatin-Induced Chronic Nephrotoxicity by Inhibiting Cell Inflammation and Apoptosis. Biomedicine & Pharmacotherapy, 147, Article ID: 112701. [Google Scholar] [CrossRef] [PubMed]
[13] Tsai, Y.S., Lin, S.W., Chen, Y.L. and Chen, C.C. (2020) Effect of Probiotics Lactobacillus paracasei GKS6, L. Plantarum GKM3, and L. Rhamnosus GKLC1 on Alleviating Alcohol-Induced Alcoholic Liver Disease in a Mouse Model. Nutrition Research and Practice, 14, 299-308. [Google Scholar] [CrossRef] [PubMed]
[14] Lai, C.H., Kuo, C.H., Chen, P.Y., Poon, S.K., Chang, C.S. and Wang, W.C. (2006) Association of Antibiotic Resistance and Higher Internalization Activity in Resistant Helicobacter pylori Isolates. The Journal of Antimicrobial Chemotherapy, 57, 466-471. [Google Scholar] [CrossRef] [PubMed]
[15] Shackelford, C., Long, G., Wolf, J., Okerberg, C. and Herbert, R. (2002) Qualitative and Quantitative Analysis of Nonneoplastic Lesions in Toxicology Studies. Toxicologic Pathology, 30, 93-96. [Google Scholar] [CrossRef] [PubMed]
[16] Schafer, K.A., Eighmy, J., Fikes, J.D., Halpern, W.G., Hukkanen, R.R., Long, G.G., Meseck, E.K., Patrick, D.J., Thibodeau, M.S., Wood, C.E. and Francke, S. (2018) Use of Severity Grades to Characterize Histopathologic Changes. Toxicologic Pathology, 46, 256-265. [Google Scholar] [CrossRef] [PubMed]
[17] Bereda, G. (2022) Peptic Ulcer Disease: Definition, Pathophysiology, and Treatment. Journal of Biomedical and Biological Sciences, 1, 1-10.
[18] Sachs, G. and Wallmark, B. (1989) The Gastric H , K -ATPase: The Site of Action of Omeprazole. Scandinavian Journal of Gastroenterology, 24, 3-11. [Google Scholar] [CrossRef] 
[19] Yibirin, M., De Oliveira, D., Valera, R., Plitt, A.E. and Lutgen, S. (2021) Adverse Effects Associated with Proton Pump Inhibitor Use. Cureus, 13, e12759. [Google Scholar] [CrossRef] [PubMed]
[20] Yang, R., Zhao, X., Wu, W. and Shi, J. (2021) Potential of Probiotics for Use as Functional Foods in Patients with Non-Infectious Gastric Ulcer. Trends in Food Science & Technology, 111, 463-474. [Google Scholar] [CrossRef] 
[21] Li, S.C., Hsu, W.F., Chang, J.S. and Shih, C.K. (2019) Combination of Lactobacillus acidophilus and Bifidobacteriumanimalis Subsp. Lactis Shows a Stronger Anti-Inflammatory Effect than Individual Strains in HT-29 Cells. Nutrients, 11, Article 969. [Google Scholar] [CrossRef] [PubMed]
[22] Dykstra, N.S., Hyde, L., Adawi, D., Kulik, D., Ahrne, S.I.V., Molin, G. and Mack, D.R. (2011) Pulse Probiotic Administration Induces Repeated Small Intestinal Muc3 Expression in Rats. Pediatric Research, 69, 206-211. [Google Scholar] [CrossRef] 
[23] Lam, E.K.Y., Yu, L., Wong, H.P.S., Wu, W.K.K., Shin, V.Y., Tai, E.K.K., So, W.H.L., Woo, P.C.Y. and Cho, C.H. (2007) Probiotic Lactobacillus rhamnosus GG Enhances Gastric Ulcer Healing in Rats. European Journal of Pharmacology, 565, 171-179. [Google Scholar] [CrossRef] [PubMed]
[24] Hu, Y., Zhang, M., Lu, B. and Dai, J. (2016) Helicobacter pylori and Antibiotic Resistance, a Continuing and Intractable Problem. Helicobacter, 21, 349-363. [Google Scholar] [CrossRef] [PubMed]
[25] Kubosawa, Y., Mori, H., Kinoshita, S., Nakazato, Y., Fujimoto, A., Kikuchi, M., Nishizawa, T., Suzuki, M. and Suzuki, H. (2019) Changes of Gastric Ulcer Bleeding in the Metropolitan Area of Japan. World Journal of Gastroenterology, 25, 6342-6353. [Google Scholar] [CrossRef] [PubMed]
[26] Rasheed, W., Dharmarpandi, G., Anil, M., Ishfaque, S., Anees, M. and Qureshi, S.N. (2023) S819 Peptic Ulcer Disease Secondary to the Rare Etiologies Carries the Highest Mortality: A National Population-Based Study. The American Journal of Gastroenterology, 118, S604-S605. [Google Scholar] [CrossRef] 

为你推荐